Residencies and Fellowships
GSK has a rich history of collaboration with leading US academic institutions through sponsorship of joint fellowship programs. Currently, our programs focus on Medical Affairs, Regulatory Affairs, Pharmaceutical Outcomes Research, and drug/medical information. Most graduates of these programs have gone on to successful industry and/or academic careers.
We sponsor fellowship and residency opportunities with two major North Carolina universities: UNC-Chapel Hill and Duke. Core areas of study include:
- US Medical Affairs Fellowship (UNC; PharmD or PhD; 2 years)
- Regulatory Affairs Fellowship (UNC; PharmD, PhD, or MD; 2 years)
- Pharmaceutical Outcomes Research Fellowship (UNC; PharmD, PhD, or MD; 2 years)
- Drug/Medical Information Residency (Duke; PharmD; 1 year)
US Medical Affairs Fellowship (PharmD or PhD)
While at GSK, the fellows learn the fundamentals of collecting and communicating the information that health care providers and payers need to make the decision to utilize a new drug. The fellow will work alongside of industry experts in global medical affairs, commercial, regulatory affairs, legal, health outcomes, clinical research, and global clinical safety and pharmacovigilance.
During the fellowship, the fellow will conduct strategic reviews of the medical literature and the competitive environment to identify data and educational gaps to enhance patient care. The fellow will also gain an understanding of the laws, regulations and policies required to ensure appropriate interactions with health care professionals, participate in medical content development and review and communication of scientific information for internal and field based colleagues, participate in medical review of promotional materials, and participate in interactions with external experts to provide medical support for congress meetings and to support launch preparations for new medicines or new indications or label extensions of existing medicines.
This training will prepare the fellow for a career in the pharmaceutical industry, a contract research organization, academia, or clinical practice.
Regulatory Affairs Fellowship (PharmD, PhD, or MD)
This fellowship provides practical training and experience in the regulatory requirements and the regulatory strategic considerations in global drug development. Through a combination of academic and industry training, the fellow will develop an in-depth understanding of Regulatory Affairs and the drug development process from pre-clinical to post-marketing.
While at GSK, the fellows will be assigned to work in a particular therapeutic group within the Global Regulatory Affairs organization. The fellow will work with a Global Regulatory Lead (GRL) or GRA US-Regional Rep who are accountable to ensure the development of appropriate global and regional regulatory strategy(s) and their execution for assigned products in drug development. The regulatory strategy is aligned and consistent with the overall Medicine Development Strategy. There will also be opportunities to gain cross-functional experience through projects in regulatory advertising & promotion, labeling, CMC regulatory and regulatory policy & intelligence.
For the first six months, the regulatory affairs fellows will spend the majority of their time at the University of North Carolina Eshelman School of Pharmacy taking classes in drug development, research and methodology, and leadership. In addition, they participate in various regulatory related activities at UNC and spend an increasing amount of time at GSK. The fellows participate in unique preparatory program at Duke University that prepares the fellow for Regulatory Affairs Certification (RAC) in US, European, and Canadian regulations. Discussions are ongoing for a potential 2-3 month rotation with FDA.
Fellows will spend the first 6 – 12 months in North Carolina and transition to the GSK R&D facilities in Philadelphia for the remaining 12 – 18 months of the program.
The fellowship will provide experience and training in:
- Regulatory strategy development, use and interpretation of regulations and guidelines, and interaction with regulatory agencies
- Principles of regulatory agency review processes in the US, Europe, emerging markets, Asia Pacific, and Canada
- Pharmaceutical product development and evaluation
- Wide variety of regulatory submissions, including IND, CTA. Pediatric plans, formal meeting requests, scientific advice, NDA, MAA and annual reports
- Research design and methodology, including innovative tools to support accelerated development programs
- Leadership behaviors
- Seminars and presentations
Pharmaceutical Outcomes Research Fellowship
(PharmD, PhD, or MD)
This fellowship program will provide the training and experience needed to compete successfully for positions as a health outcomes researcher in consulting, and the pharmaceutical industry.
Preferred qualifications for the position are a PharmD, PhD, or MD. The ideal candidate should possess strong analytical skills, excellent written and verbal communication, good organizational abilities, and evidence of leadership and team work. A background in pharmaceutical outcomes research is preferred. The candidate should be self-directed and self-motivated.
The fellowship program starts July 1st. The fellowship offers a competitive stipend, and provides health insurance, paid vacation, and compensation for travel to one professional meeting each year.
The first year in the fellowship will be heavily didactic. Depending on each individual student, training will be received through enrollment in courses related to research methods, statistics, pharmacoepidemiology, pharmaceutical policy, and/or pharmacoeconomics within the UNC Eshelman School of Pharmacy and the UNC Gillings School of Public Health. There will be opportunities for fellows to design and conduct various research projects under the mentorship of faculty at the UNC Eshelman School of Pharmacy as part of the learning process. In addition, the fellow will spend time at least 20% of their time working in the US health outcomes department at GlaxoSmithKline.
Fellows will spend most of their second year at GSK in the health outcomes research department. Within GSK, the fellow will be exposed to the application of health outcomes research for diseases and/or medications that are relevant to the United States and will concentrate on improving the competency in generation of health outcomes evidence related to marketed pharmaceuticals in the US market. In addition, the program will emphasize strategic thinking, working within a matrix environment, understanding of the US payer market, communications of evidence to external and internal customers, handling of study budgets, and study conduct. Students may have additional opportunities to enroll in courses through UNC during the second year of their fellowship to supplement information obtained during year one as well as finish up any research started during the first year.
Drug/Medical Information Residency
This 12-month residency provides specialty drug information training in the GSK Medical Information Department at the Research Triangle Park, NC campus (6 months) with additional clinical and drug information experiences at Duke University Hospital (6 months).
The resident is a member of a therapeutic team at GSK, participating in activities that mirror those of a scientist. Activities for the resident include written and oral communication with healthcare professionals, evidence-based literature evaluation, product-specific database management, review of promotional materials, sales representative training, managed care dossier development and provision of medical expertise and support to various other departments within the company.
The 943-bed Duke University Hospital is consistently rated as one of the top hospitals in the US. Residents participate in clinical training and hospital-based drug information experiences at Duke University Hospital’s Department of Pharmacy, comprised of 240 full time employee positions. Residents study and practice under the supervision of specialists in Drug Information, Medication Safety, Quality Improvement, Informatics, and Investigational Drugs. The residency strengthens competencies in literature evaluation, clinical trial design, drug policy management, medication safety, adverse drug event analysis and direct patient care.
Development of critical thinking skills, project management, presentation preparation and delivery are important focuses of the training. The resident will complete formal residency projects at both GSK and Duke University Hospital and will present them at national scientific meetings. Residents also have opportunities to teach various allied health professionals including medical, nursing, and physical therapy students as well as to precept PharmD candidates on rotation.
For further information about the residency and application process please visit the Duke website.
UNC – GSK Fellowship Programs
- US Medical Affairs (UNC; PharmD or PhD; 2 years)
- Regulatory Affairs (UNC; PharmD, PhD, or MD; 2 years)
- Pharmaceutical Outcomes Research (UNC; PharmD, PhD, or MD; 2 years)
The 2-year fellowships begin on July 1st.
See http://pharmacydpetfellowships.web.unc.edu/ for instructions on submitting an application.
If you have questions regarding the fellowship program please contact firstname.lastname@example.org
The deadline for early consideration is November 15th. The final deadline to apply is January 1st. Early applications are encouraged.
Drug/Medical Information Residency (PharmD)
The residency will begin July 1st. Application materials must be sent electronically by January 1st. For further information about the residency and application process please visit the Duke website.